Authors:
Vickers, SP
Easton, N
Malcolm, CS
Allen, NH
Porter, RH
Bickerdike, MJ
Kennett, GA
Citation: Sp. Vickers et al., Modulation of 5-HT2A receptor-mediated head-twitch behaviour in the rat by5-HT2C receptor agonists, PHARM BIO B, 69(3-4), 2001, pp. 643-652
Authors:
Wood, MD
Reavill, C
Trail, B
Wilson, A
Stean, T
Kennett, GA
Lightowler, S
Blackburn, TP
Thomas, D
Gager, TL
Riley, G
Holland, V
Bromidge, SM
Forbes, IT
Middlemiss, DN
Citation: Md. Wood et al., SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety, NEUROPHARM, 41(2), 2001, pp. 186-199
Citation: Sp. Vickers et al., Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors, NEUROPHARM, 41(2), 2001, pp. 200-209
Authors:
Stanhope, KJ
Mirza, NR
Bickerdike, MJ
Bright, JL
Harrington, NR
Hesselink, MB
Kennett, GA
Lightowler, S
Sheardown, MJ
Syed, R
Upton, RL
Wadsworth, G
Weiss, SM
Wyatt, A
Citation: Kj. Stanhope et al., The muscarinic receptor agonist xanomeline has an anti psychotic-like profile in the rat, J PHARM EXP, 299(2), 2001, pp. 782-792
Authors:
Bromidge, SM
Dabbs, S
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Saunders, DV
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroaryloxy)heteroaryl]carbamoyl]indolines: Novel and selective 5-HT2C receptor inverse agonists with potential as antidepressant/anxiolyticagents, BIOORG MED, 10(16), 2000, pp. 1863-1866
Authors:
Bromidge, SM
Davies, S
Duckworth, DM
Forbes, IT
Jones, GE
Jones, J
King, FD
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Riley, GJ
Trail, B
Wood, MD
Citation: Sm. Bromidge et al., 1-[2-[(heteroarylmethoxy)aryl]carbamoyl]indolines are selective and orallyactive 5-HT2C receptor inverse agonists, BIOORG MED, 10(16), 2000, pp. 1867-1870
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gaster, LM
Ham, P
Jones, GE
King, FD
Mulholland, KR
Saunders, DV
Wyman, PA
Blaney, FE
Clarke, SE
Blackburn, TP
Holland, V
Kennett, GA
Lightowler, S
Middlemiss, DN
Trail, B
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Biarylcarbamoylindolines are novel and selective 5-HT2C receptor inverse agonists: Identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent, J MED CHEM, 43(6), 2000, pp. 1123-1134
Citation: Sp. Vickers et al., Comparative effects of continuous infusion of mCPP, Ro 60-0175 and d-fenfluramine on food intake, water intake, body weight and locomotor activity inrats, BR J PHARM, 130(6), 2000, pp. 1305-1314
Authors:
Bromidge, SM
Dabbs, S
Davies, DT
Davies, S
Duckworth, DM
Forbes, IT
Gadre, A
Ham, P
Jones, GE
King, FD
Saunders, DV
Thewlis, KM
Vyas, D
Blackburn, TP
Holland, V
Kennett, GA
Riley, GJ
Wood, MD
Citation: Sm. Bromidge et al., Model studies on a synthetically facile series of N-substituted phenyl-N '-pyridin-3-yl ureas leading to 1-(3-pyridylcarbamoyl) indolines that are potent and selective 5-HT2C/2B receptor antagonists, BIO MED CH, 7(12), 1999, pp. 2767-2773
Citation: Ga. Kennett et al., Anxiolytic-like actions of BW 723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated, NEUROPHARM, 37(12), 1998, pp. 1603-1610